Near-infrared laser adjuvant for influenza vaccine

Satoshi Kashiwagi, Jianping Yuan, Benjamin Forbes, Mathew L. Hibert, Eugene L Q Lee, Laura Whicher, Calum Goudie, Yuan Yang, Tao Chen, Beth Edelblute, Brian Collette, Laurel Edington, James Trussler, Jean Nezivar, Pierre Leblanc, Roderick Bronson, Kosuke Tsukada, Makoto Suematsu, Jeffrey Dover, Timothy BraunsJeffrey Gelfand, Mark C. Poznansky

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, nearinfrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.

Original languageEnglish
Article numbere82899
JournalPLoS One
Volume8
Issue number12
DOIs
Publication statusPublished - 2013 Dec 11

Fingerprint

Infrared lasers
Influenza Vaccines
influenza
adjuvants
lasers
Lasers
Vaccines
vaccines
skin (animal)
Human Influenza
Skin
vaccine adjuvants
mice
chemokines
dendritic cells
Immunologic Adjuvants
Biological Factors
Chemokines
Dendritic Cells
Immunoglobulin E

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kashiwagi, S., Yuan, J., Forbes, B., Hibert, M. L., Lee, E. L. Q., Whicher, L., ... Poznansky, M. C. (2013). Near-infrared laser adjuvant for influenza vaccine. PLoS One, 8(12), [e82899]. https://doi.org/10.1371/journal.pone.0082899

Near-infrared laser adjuvant for influenza vaccine. / Kashiwagi, Satoshi; Yuan, Jianping; Forbes, Benjamin; Hibert, Mathew L.; Lee, Eugene L Q; Whicher, Laura; Goudie, Calum; Yang, Yuan; Chen, Tao; Edelblute, Beth; Collette, Brian; Edington, Laurel; Trussler, James; Nezivar, Jean; Leblanc, Pierre; Bronson, Roderick; Tsukada, Kosuke; Suematsu, Makoto; Dover, Jeffrey; Brauns, Timothy; Gelfand, Jeffrey; Poznansky, Mark C.

In: PLoS One, Vol. 8, No. 12, e82899, 11.12.2013.

Research output: Contribution to journalArticle

Kashiwagi, S, Yuan, J, Forbes, B, Hibert, ML, Lee, ELQ, Whicher, L, Goudie, C, Yang, Y, Chen, T, Edelblute, B, Collette, B, Edington, L, Trussler, J, Nezivar, J, Leblanc, P, Bronson, R, Tsukada, K, Suematsu, M, Dover, J, Brauns, T, Gelfand, J & Poznansky, MC 2013, 'Near-infrared laser adjuvant for influenza vaccine', PLoS One, vol. 8, no. 12, e82899. https://doi.org/10.1371/journal.pone.0082899
Kashiwagi S, Yuan J, Forbes B, Hibert ML, Lee ELQ, Whicher L et al. Near-infrared laser adjuvant for influenza vaccine. PLoS One. 2013 Dec 11;8(12). e82899. https://doi.org/10.1371/journal.pone.0082899
Kashiwagi, Satoshi ; Yuan, Jianping ; Forbes, Benjamin ; Hibert, Mathew L. ; Lee, Eugene L Q ; Whicher, Laura ; Goudie, Calum ; Yang, Yuan ; Chen, Tao ; Edelblute, Beth ; Collette, Brian ; Edington, Laurel ; Trussler, James ; Nezivar, Jean ; Leblanc, Pierre ; Bronson, Roderick ; Tsukada, Kosuke ; Suematsu, Makoto ; Dover, Jeffrey ; Brauns, Timothy ; Gelfand, Jeffrey ; Poznansky, Mark C. / Near-infrared laser adjuvant for influenza vaccine. In: PLoS One. 2013 ; Vol. 8, No. 12.
@article{ec700ee50fb846f5b2edeabeb6584e5b,
title = "Near-infrared laser adjuvant for influenza vaccine",
abstract = "Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, nearinfrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.",
author = "Satoshi Kashiwagi and Jianping Yuan and Benjamin Forbes and Hibert, {Mathew L.} and Lee, {Eugene L Q} and Laura Whicher and Calum Goudie and Yuan Yang and Tao Chen and Beth Edelblute and Brian Collette and Laurel Edington and James Trussler and Jean Nezivar and Pierre Leblanc and Roderick Bronson and Kosuke Tsukada and Makoto Suematsu and Jeffrey Dover and Timothy Brauns and Jeffrey Gelfand and Poznansky, {Mark C.}",
year = "2013",
month = "12",
day = "11",
doi = "10.1371/journal.pone.0082899",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Near-infrared laser adjuvant for influenza vaccine

AU - Kashiwagi, Satoshi

AU - Yuan, Jianping

AU - Forbes, Benjamin

AU - Hibert, Mathew L.

AU - Lee, Eugene L Q

AU - Whicher, Laura

AU - Goudie, Calum

AU - Yang, Yuan

AU - Chen, Tao

AU - Edelblute, Beth

AU - Collette, Brian

AU - Edington, Laurel

AU - Trussler, James

AU - Nezivar, Jean

AU - Leblanc, Pierre

AU - Bronson, Roderick

AU - Tsukada, Kosuke

AU - Suematsu, Makoto

AU - Dover, Jeffrey

AU - Brauns, Timothy

AU - Gelfand, Jeffrey

AU - Poznansky, Mark C.

PY - 2013/12/11

Y1 - 2013/12/11

N2 - Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, nearinfrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.

AB - Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, nearinfrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.

UR - http://www.scopus.com/inward/record.url?scp=84892406414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892406414&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0082899

DO - 10.1371/journal.pone.0082899

M3 - Article

C2 - 24349390

AN - SCOPUS:84892406414

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e82899

ER -